首页> 外国专利> GENERATION OF MONOCLONAL ANTIBODIES TARGETING RESPIRATORY SYNCYTIAL VIRUS (RSV) USING REGULATORY B CELLS FROM NEWBORNS (NBREGS)

GENERATION OF MONOCLONAL ANTIBODIES TARGETING RESPIRATORY SYNCYTIAL VIRUS (RSV) USING REGULATORY B CELLS FROM NEWBORNS (NBREGS)

机译:利用新生儿(NBREGS)调节性B细胞产生针对呼吸道合胞病毒(RSV)的单克隆抗体

摘要

The invention pertains to methods for preparing libraraies of antibodies or fragments thereof, and methods for preparing a monoclonal antibody or fragments thereof that bind, preferably specifically, to an antigen of interest, based on the use of nBreg cells. The invention further pertains to the antibody library susceptible to be produced by the methods of the invention. The invention further pertains to the monoclonal antibodies and fragments thereof susceptible to be produced by the methods of the invention, as well as the monoclonal antibodies derived from the antibody library, the pharmaceutical compositions comprisising thereof, and their use as a medicine. The invention more particularly pertains to monoclonal antibodies derived from nBregs can be used for prophylactic and therapeutic purposes for RSV infections.
机译:本发明涉及基于nBreg细胞的使用,制备抗体或其片段的文库的方法,以及制备优选地特异性结合感兴趣抗原的单克隆抗体或其片段的方法。本发明进一步涉及易于通过本发明的方法产生的抗体文库。本发明进一步涉及易于通过本发明的方法产生的单克隆抗体及其片段,以及衍生自抗体文库的单克隆抗体,包含其的药物组合物及其作为药物的用途。本发明更特别地涉及衍生自nBreg的单克隆抗体,其可用于RSV感染的预防和治疗目的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号